Navigation Links
Asia Pacific Pharmaceutical Market: Strategic Assessments of Leading Suppliers
Date:10/5/2011

NEW YORK, Oct. 5, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Asia Pacific Pharmaceutical Market: Strategic Assessments of Leading Suppliers

http://www.reportlinker.com/p0651430/Asia-Pacific-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

This report provides industry executives with strategically significant competitor information and analysis of the leading players in the Asia Pacific pharmaceutical market.

The report provides a worldwide strategic overview of the pharmaceutical market, including:

• Sales forecast for major product segments: ethical, OTC, generics.

• Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others.

In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies.

The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.

The report's major objectives include:

• To establish a comprehensive, factual, annually updated and cost-effective information based on performance, capabilities, goals and strategies of the leading players in the Asia Pacific pharmaceutical market.

• To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis the leading competitors.

• To assist potential market entrants in evaluating prospective acquisition and joint venture candidates.

• To complement organizations' internal competitor information gathering efforts with strategic analysis, data interpretation and insight.

Contains 1,353 pages and 127 tables

Table of Contents

Abbott

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

AstraZeneca

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Bristol-Myers Squibb

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Eli Lilly

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic DirectionGlaxoSmithKline

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Johnson & Johnson

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Merck

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Novartis

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic DirectionPfizer

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Roche

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Sanofi-Aventis

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Wyeth

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic DirectionList of Tables

Abbott Sales and Operating Profit Growth

Abbott Sales by Therapeutic Category/Business

Abbott Sales Growth by Therapeutic Category/business

Abbott Sales by Major Drug/Business

Abbott Sales Growth by Major Drug/Business

Abbott Sales by Major Drug/Business and Geographic Region

Abbott Sales by Geographic Region and Country

Abbott Sales Growth by Geographic Region and Country

AstraZeneca Sales and Operating Profit Growth

AstraZeneca Sales by Therapeutic Category/Business

AstraZeneca Sales Growth by Therapeutic Category/business

AstraZeneca Sales by Major Drug/Business

AstraZeneca Sales Growth by Major Drug/Business

AstraZeneca Sales by Major Drug/Business and Geographic Region

AstraZeneca Sales by Geographic Region and Country

AstraZeneca Sales Growth by Geographic Region and Country

Bristol-Myers Squibb Sales and Operating Profit Growth

Bristol-Myers Squibb Sales By Major Drug and Geographic Region

Bristol-Myers Squibb Sales Growth by Major Drug

Bristol-Myers Squibb Sales By Geographic Region

Bristol-Myers Squibb Estimated Sales Growth By Geographic Region

Historical Financials

Bristol-Myers Squibb Sales and Operating Profit growth

Bristol-Myers Squibb Sales by Major Division

Bristol-Myers Squibb Sales by Major Division and Geographic Region

Bristol-Myers Squibb Sales Growth by Major Division

Bristol-Myers Squibb Sales by Therapeutic Category

Bristol-Myers Squibb Sales by Therapeutic Category and Geographic Region

Bristol-Myers Squibb Sales Growth by Therapeutic Category

Bristol-Myers Squibb Sales by Major Drug

Bristol-Myers Squibb Sales Growth by Major Drug

Bristol-Myers Squibb Sales by Product Line

Bristol-Myers Squibb Sales Growth by Product Line

Bristol-Myers Squibb Sales by Geographic Region

Bristol-Myers Squibb Sales Growth by Geographic Region

Bristol-Myers Squibb Other Health Care Sales by Product

Bristol-Myers Squibb Sales Growth by Geographic Region

Eli Lilly Sales and Operating Profit Growth

Eli Lilly Sales by Therapeutic Category

Eli Lilly Sales Growth by Therapeutic Category

Eli Lilly Sales by Major Product

Eli Lilly Sales Growth by Major Drug

Eli Lilly Sales by Geographic Region

Eli Lilly Sales Growth by Geographic Region

Eli Lilly Sales and Operating Profit Growth

GlaxoSmithKline Sales by Business Segment

GlaxoSmithKline Sales Growth by Business Segment

GlaxoSmithKline Operating Profit and Margins by Business Segment

GlaxoSmithKline Operating Profit by Business Segment GlaxoSmithKline Sales and Operating Profit Growth

GlaxoSmithKline Sales by Major Drug

GlaxoSmithKline Sales by Drug and Geographic Region

GlaxoSmithKline Sales by Therapeutic Category

GlaxoSmithKline Sales Growth by Therapeutic Category

GlaxoSmithKline Sales by Geographic Region and Country

GlaxoSmithKline Sales Growth by Geographic Region

GlaxoSmithKline Consumer Healthcare Sales by Product Line

GlaxoSmithKline Consumer Healthcare Sales Growth By Product Line

Johnson & Johnson Sales by Geographic Region and Country

Johnson & Johnson Sales Growth by Geographic Region

Johnson & Johnson Sales by Business Segment and Geographic Region

Johnson & Johnson Sales and Operating Profit Growth

Johnson & Johnson Sales by Major Drug

Johnson & Johnson Pharmaceutical Sales Growth by Major Drug

Johnson & Johnson Consumer Segment Sales by Product Line

Johnson & Johnson Consumer Segment Sales Growth by Product Line

Merck Sales and Operating Profit Growth

Merck Sales by Geographic Region

Merck Sales Growth by Geographic Region

Merck Sales by Therapeutic Category

Merck Sales Growth by Therapeutic Category

Merck Sales by Major Drug

Merck Sales Growth by Major Drug

Merck Sales by Major Drug and Geographic Region

Novartis Sales and Operating Profit Growth

Novartis Sales by Business Segment

Novartis Sales Growth by Business Segment

Novartis Operating Profit by Business Segment

Novartis Operating Profit Growth by Business Segment

Novartis Sales by Country

Novartis Sales Growth by Country

Novartis Sales by Therapeutic Category

Novartis Sales Growth by Therapeutic Category

Novartis Sales of Top 20 Drugs

Novartis Sales Growth by Major Drug

Pfizer Sales by Division

Pfizer Sales and Operating Profit Growth

Pfizer Sales by Therapeutic Category

Pfizer Sales by Major Product

Pfizer Sales Growth by Major Product

Pfizer Sales by Geographic Region

Pfizer Sales Growth by Geographic Region

Roche Sales and Operating Profit Growth

Roche Sales by Major Division

Roche Sales Growth by Business Segment

Roche Sales by Geographic Region

Roche Sales Growth by Geographic Region

Roche Sales and Operating Profit Growth

Roche Sales by Division

Roche Operating Profit by DivisionRoche Operating Profit Growth by Division

Roche Sales by Therapeutic Category

Roche Sales of Top 20 Products

Sanofi-Aventis Sales and Operating Profit Growth

Sanofi-Aventis Sales by Business Segment

Sanofi-Aventis Sales Growth by Business Segment

Sanofi-Aventis Sales of Top 15 Drugs

Sanofi-Aventis Sales Growth of Top 15 Drugs

Sanofi-Aventis Sales of 15 Major Drugs and Geographic Region

Sanofi-Aventis Sales by Geographic Region

Sanofi-Aventis Vaccine Sales by Major Product

Wyeth Sales by Business Segment

Wyeth Sales Growth by Business Segment

Wyeth Sales and Operating Profit Growth

Wyeth Sales by Therapeutic Category

Wyeth Sales by Major Drug

Wyeth Consumer Healthcare Sales by Product

Wyeth Consumer Healthcare Sales Growth by Product

To order this report:

Drug and Medication Industry: Asia Pacific Pharmaceutical Market: Strategic Assessments of Leading Suppliers

Drug and Medication Business News

More  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
2. Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report
3. PacificGMP Completes GMP Product Fill for Trius Therapeutics
4. Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
5. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
6. Health Robotics Reaches 100% Asia-Pacific Coverage Through its New Exclusive Distribution Contract With BioRobotics in Korea
7. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
8. PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference
9. American Pacific to Release Financial Results and Hold Fiscal 2010 Second Quarter Investor Teleconference
10. Swedish Cancer Institute and Elekta Launch Renewed Partnership Agreement to Continue the Flow of World-Class Technology, Services to Cancer Patients in the Pacific Northwest and Beyond
11. Pacific Bridge Medical to Host Taiwan Drug Registration Webinar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Calif. , March 27, 2017  Sanderling ... acquired by Ethicon, a division of Johnson & ... System for the treatment of gastro-esophageal reflux disease ... sphincter augmentation (MSA) technology and the procedure is ... centers. Torax Medical was founded by ...
(Date:3/27/2017)... NEW YORK , March 27, 2017 ... ... that adult use in states where cannabis is legal will generate ... $559 million will be from cannabis specific taxes, such as ... remaining $96 million will be earned from state sales taxes that ...
(Date:3/27/2017)... INVICTUS MD STRATEGIES CORP. ("Invictus MD" or the "Company") (CSE: ... to announce it has received conditional approval to list ... Exchange.  Receiving the conditional listing approval ... for Invictus-MD. Some of which include: ... ("AB Labs"), a Licensed Producer under the Access to ...
Breaking Medicine Technology:
(Date:3/28/2017)... (PRWEB) , ... March 28, ... ... a non-profit medical society dedicated to advancing the science and clinical practice ... from its RSSearch Patient Registry, a multi-institutional, observational registry established to standardize ...
(Date:3/28/2017)... ... 28, 2017 , ... WHO: , Dr. Paul Thomas; Dr. Brian Hooker; Dr. ... and PhD scientists will speak to the press on behalf of over 200 doctors, ... independent vaccine safety commission. , WHERE: , Zenger Room, National Press Club, 529 ...
(Date:3/28/2017)... ... March 28, 2017 , ... Award-winning medical group Allied Anesthesia ... new board chair for Orange County health care system CalOptima Friday. CalOptima announced ... former chair Mark Refowitz’s term, which runs through June 30 of this year, ...
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER TOLEDO ... found in power plant water and steam. , Chlorides and sulfates cause pitting ... leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at low ppb ...
(Date:3/28/2017)... ... 28, 2017 , ... A minimally invasive porcelain veneer is ... National Association of Dental Laboratories (NADL) is informing dentists about the benefits of ... utilizing dental laboratories and technicians that create these veneers. , According to ...
Breaking Medicine News(10 mins):